Arthur Bedrosian, CEO, Lannett Company Inc 00:00:00

Share On Facebook Share On Twitter

Lannett Company CEO Arthur Bedrosian on business in the generic market and the $1.23 billion acquisition of Kremers Urban Pharmaceuticals.

Recent Videos